HOME >> BIOLOGY >> NEWS
Blocking cell suicide switch fails to stop prion damage in mouse brains

St. Louis, Dec. 21, 2004 -- Researchers knew that prions, the misfolded proteins that cause mad cow disease and other brain disorders, were killing off a class of important brain cells in a transgenic mouse model. But when they found a way to rescue those cells, they were astonished to discover the mice still became sick.

Now they believe previous efforts to find the beginnings of the mouse disorder may have been focused on the wrong part of the brain cell and are plotting new directions for research.

In a study that appears in the Jan. 1 issue of the Proceedings of the National Academy of Sciences, scientists report evidence that clinical symptoms in the mice are produced by damage to synapses, the areas where nerve cell branches come together for communication.

"This could have important therapeutic implications," says senior author David Harris, M.D, Ph.D, professor of cell biology and physiology at Washington University School of Medicine in St. Louis. "There's a great deal of effort being put into developing treatments for neurodegenerative disorders that would inhibit neuron death. Our results suggest that if we just prevent cell death without doing something to maintain the functionality of the synapse, patients may still get sick."

Harris notes that the findings also link prion diseases, which are relatively rare, to more common neurodegenerative disorders like Alzheimer's disease, where recent evidence has also elevated the importance of damage to synapses.

Because of the bizarre methods by which prions spread and cause disease, they have only recently gained widespread acceptance as the source of several disorders that rapidly devastate the brains of humans, cows, deer and sheep.

In these disorders, the most infamous of which is mad cow disease, copies of a normal brain protein, PrP, fold themselves into abnormal shapes, dramatically altering the proteins' properties. Genetic mutations can increase ch
'"/>

Contact: Michael C. Purdy
purdym@wustl.edu
314-286-0122
Washington University School of Medicine
21-Dec-2004


Page: 1 2 3

Related biology news :

1. Blocking beta1-integrin to treat cancer
2. Blocking a premature aging syndrome with anticancer drugs
3. Blocking blood vessels provides new option for large group of advanced lung cancer patients
4. Blocking COX-1 slows tumor growth in mice
5. Blocking PLK-1 to beat bladder cancer
6. Blocking neurodegeneration by radiation and bone marrow transfer prevents inherited glaucoma in mice
7. Blocking cell signaling can stymie viral infections, study shows
8. Protein averts cell suicide but might contribute to cancer
9. A beneficial suicide
10. University of Minnesota researchers take new look at cellular suicide
11. Pepper component hot enough to trigger suicide in prostate cancer cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... July 18, 2019 , ... Flagship Biosciences, the advanced tissue ... its executive team as Vice President of Operations. Ms. James brings a wealth ... role, Ms. James is responsible for ensuring on-time delivery of all projects by ...
(Date:7/17/2019)... ... July 15, 2019 , ... RCH Solutions (RCH), ... Healthcare companies, announces the availability of new specialty advisory practice, a Public Cloud ... and emerging bio-pharma companies interested in achieving specific outcomes related to public Cloud ...
(Date:7/17/2019)... CITY, S.D. (PRWEB) , ... July 16, 2019 , ... ... to form, or to detect bone loss before it causes osteoporosis. For South Dakota ... , “This is potentially a game-changer in terms of our ability to monitor ...
Breaking Biology News(10 mins):
(Date:5/15/2019)... ... May 16, 2019 , ... Emulsifiers ... result, food and beverage products rely on these ingredients to create stable quality ... label declarations. This paradigm shift triggers food formulators to seek out alternatives for ...
(Date:5/14/2019)... ... May 14, 2019 , ... Gateway Genomics , a leading developer ... from 2,500 to 5,000 square feet. , “This past year has seen exponential ... Gateway Genomics CEO, Chris Jacob. “The SneakPeek At-Home test, which is mailed directly to ...
(Date:5/7/2019)... ... May 06, 2019 , ... ... for the growing number of repositories being asked to store cellular products ... the team of contributors who are world leaders, who have shared their expertise ...
(Date:5/4/2019)... BROOK, N.J. (PRWEB) , ... May 03, 2019 ... ... electrophysiology, announces the release of the Diopsys® ffERG/Photopic Negative Response vision ... of glaucoma. , By 2050, it is estimated that 6.3 million Americans will ...
Breaking Biology Technology:
Cached News: